The highest quality delivery through foresight and accountability
Our general medicine thought leaders provide innovative development strategies and principled trial design and conduct. They work hand in hand in with market access and regulatory experts, operational teams, and feasibility leaders to ensure that your trials are conducted to exacting standards. General Medicine M.D.s are keenly focused not only on today’s landscape but what the future portends, providing both strategic insight and operational nimbleness across all phases of development.
Get focused support, no matter the size of the study
Our General Medicine group has global expertise in cardiovascular medicine, respiratory medicine, endocrinology and metabolic diseases, nephrology, and women’s health and genitourinary medicine.
Because the needs of patients are at the core of all that we do, each program, from highly prevalent conditions to ultra-rare diseases, and from mega trials with thousands of patients, to trials with very few patients, receives our focus. But we do not just execute. We seek and scrutinize the latest advances in study design and technologies to catapult your program to success.
What people need to know about clinical research is that many of their predecessor drugs that we all sort of take for granted started from clinical research. In fact, they all started from clinical research. And that we do need to sort of keep these pipelines going so they can be improved or address a totally unmet need that has never had a drug approved for that indication before.
So general medicine includes nephrology, cardiology, respiratory, endocrine, and women's health. It's actually a really interesting space because we see patients with chronic diseases, chronic renal failure or kidney disease, but we also see people who are just living their lives, like in the women's health space, who are either contracepting or are undergoing fertility treatments. So I think what I really thrive on at Parexel is where the innovations that we're seeing, where you're seeing huge unmet needs and we are addressing those with our sponsors and clients.
I think that our group really sort of mirrors what you would see in the general population in terms of what you would see if you did a survey across the population. At the end of the day, it's absolutely about the patient first. They’re so invested, not in only their own health care, but also in what this can bring to patients all over the world.
Our experts in general medicine
Nancy Kivel, M.D.
Senior Vice President, Medical Sciences
Anthony Bohnert, M.D.
Global TA Section Head, Respiratory
Juergen Schaper
Vice President, Global Medical Sciences
Viviana Reidel, M.D.
Senior Medical Director
Roxana Robini
Senior Medical Director, Head, Medical Sciences
Lazar Mandinov, M.D., Ph.D.
Global TA Section Head, Cardiovascular
Harmeet Singh, M.D.
Senior Medical Director, Global TA Head, Nephrology
Mwango Kashoki, M.D., M.P.H.
Senior Vice President, Global Head of Regulatory Strategy
Our experts in general medicine
Nancy Kivel, M.D.
Senior Vice President, Medical Sciences
Anthony Bohnert, M.D.
Global TA Section Head, Respiratory
Juergen Schaper
Vice President, Global Medical Sciences
Viviana Reidel, M.D.
Senior Medical Director
Roxana Robini
Senior Medical Director, Head, Medical Sciences
Lazar Mandinov, M.D., Ph.D.
Global TA Section Head, Cardiovascular
Experience in the past 5 years with general medicine
+
clinical projects
+
enrolled patients
+
sites
Indications
Cardiovascular
We have far-reaching experience in cardiovascular trials across the entire spectrum of drugs and medical devices, including heart failure, hypertension, pulmonary hypertension, atherosclerosis and myocardial infarction, atrial fibrillation, and thrombosis, to name a few. Our board-certified cardiologists, top-notch biostatisticians, and regulatory, product development, and market access specialists are always ready to optimize study designs and develop strategy.
Two additional strengths are our adjudication services and site and ECG/imaging core laboratory networks. Our adjudication services help ensure the highest quality data, and because we are already engaged in cardiovascular projects across our site network, we’re able to accelerate timelines with our experience and agreed upon contract templates, as well as monitor sites closely to ensure high performance.
Global TA Section Head, Cardiovascular
Medical Director
Clinical Operations Leader
Senior Project Leader
Endocrinology and metabolism
Our projects cover the spectrum from small studies of rare metabolic diseases to Type 2 diabetes mega-trials enrolling thousands. We fulfill the unique needs of each study with strong site networks around the world and recruitment solutions, including both adult and pediatric studies. Sensor solutions for diabetes studies are another area of our expertise, including 21 Code of Federal Regulations (CFR) part 11–compliant continuous glucose monitoring (CGM). Our sensor solutions and endocrinology experts have collaborated on solutions to facilitate CGM and glucose-related data capture for diabetes clinical trials. Through partnerships with our vendors, we can offer an integrated central platform for real-time visualization and monitoring of CGM, blood glucose and e-diary information.
Our team includes board-certified adult and pediatric endocrinologists, certified clinical densitometrists, glucose-clamp expertise, and top-quality regulatory, market access, and biostatistics experts.
Global TA Section Head, Endocrinology
Senior Medical Director
Senior Project Leader
Nephrology and genito-urinary
As we enter a new era with breakthroughs for chronic kidney and urinary system diseases, we are here to help you overcome obstacles — like patient recruitment, payer engagement, and others. Our delivery of major studies in this area demonstrates expertise, including chronic kidney failure, diabetic and polycystic kidney diseases, nephritis, nephropathy, urinary incontinence, overactive bladder, and benign prostatic hyperplasia.
Senior Medical Director, Global TA Head, Nephrology
Senior Medical Director
Senior Project Leader
Respiratory
At Parexel, we have conducted studies in common respiratory processes involving many thousands of patients at more than 5,000 sites globally, including one of the largest observational asthma trials ever conducted. Likewise, our expertise spans to smaller studies in interstitial lung disease, cystic fibrosis, chronic cough, and orphan diseases.
Global TA Section Head, Respiratory
Senior Medical Director, Head, Medical Sciences
Senior Medical Director
Senior Medical Director
Senior Project Leader
Women’s health
While the ecosystem for women’s health drug development and marketed products has become increasingly complex, we have the experience and success to drive your trials forward. Our expertise spans across a person’s lifetime, encompassing preadolescent care, menstrual and pelvic health, contraception, fertility, pregnancy, menopausal care, and mental health. We continue to be at the cutting edge of women’s health, supporting all three women’s health products approved by the US FDA in 2020. As the field of women’s health moves beyond patients, health care providers, pharma, payors, and regulators, we are ready to partner with you to accelerate product development.
Senior Vice President, Medical Sciences
Medical Director
Associate Medical Doctor
Simona Stankeviciute, M.D., M.Sc.
Vice President, Technical
Advantages
Innovative trial designs and technology
At Parexel, we have vast expertise in innovative trial design and digital medicine. This includes virtual, decentralized, and adaptive trials, precision and translational medicine, and sensor solutions, which can make your trials not only more accessible, but more impactful.
Alliance with DSP Clinical Research
Parexel has formed a strategic alliance with DSP Clinical Research, a leading CRO specializing in reproductive endocrinology and fertility studies. This alliance builds upon more than a decade of collaboration in the United States and offers customers an enhanced offering and level of expertise in this highly specialized area. DSP, having conducted 80% of all infertility studies in the U.S. over the past 18 years, brings unparalleled expertise to complement Parexel's comprehensive CRO capabilities. Together, Parexel and DSP are positioned to accelerate sponsors’ development of safe and effective fertility therapies and set a new standard in women’s health research.
related insights
Webinar
Unlocking Success in Obesity Clinical Trials: Mastering Patient Engagement and Retention
May 15, 2025
Whitepaper
Navigating to 2030: A playbook for differentiating next-generation obesity therapies
May 2, 2025
Whitepaper
Optimize trial retention: Targeted strategies to engage patients
May 1, 2025
Whitepaper
Execute with precision: Streamline operations for rapid and reliable enrollment
May 1, 2025
Whitepaper
Anticipate regulatory expectations: Fill evidence gaps and mitigate risks
May 1, 2025
Whitepaper
Design for efficiency: Employ trial strategies to meet stakeholder needs
May 1, 2025
Playbook
Define your differentiators: Carve a unique niche in the market
May 1, 2025
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Blog
Updated European Society of Cardiology guidelines: opportunities and risks for clinical trials
Jan 21, 2025
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
AI Milestones: AI-enabled EKG reads and alerts save lives: human-AI collaboration in practice
Jun 6, 2024
related insights
Webinar
Unlocking Success in Obesity Clinical Trials: Mastering Patient Engagement and Retention
May 15, 2025
Whitepaper
Navigating to 2030: A playbook for differentiating next-generation obesity therapies
May 2, 2025
Whitepaper
Optimize trial retention: Targeted strategies to engage patients
May 1, 2025
Whitepaper
Execute with precision: Streamline operations for rapid and reliable enrollment
May 1, 2025
Whitepaper
Anticipate regulatory expectations: Fill evidence gaps and mitigate risks
May 1, 2025
Whitepaper
Design for efficiency: Employ trial strategies to meet stakeholder needs
May 1, 2025
Playbook
Define your differentiators: Carve a unique niche in the market
May 1, 2025
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Blog
Updated European Society of Cardiology guidelines: opportunities and risks for clinical trials
Jan 21, 2025
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
AI Milestones: AI-enabled EKG reads and alerts save lives: human-AI collaboration in practice
Jun 6, 2024